共 530 条
[1]
Zeiser R(2017)Acute graft-versus-host disease - biologic process, prevention, and therapy N Engl J Med 377 2167-2179
[2]
Blazar BR(2005)Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time Bone Marrow Transplant 36 757-769
[3]
Gratwohl A(2021)Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the acute leukemia working party of the european society for blood and marrow transplantation J Hematol Oncol 14 53-1163
[4]
Brand R(2012)First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation Biol Blood Marrow Transplant 18 1150-e167
[5]
Frassoni F(2020)Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation Lancet Haematol 7 e157-378
[6]
Rocha V(2013)Treatment and management of graft-versus-host disease: improving response and survival Ther Adv Hematol 4 366-1749
[7]
Niederwieser D(2020)Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial Blood 135 1739-574
[8]
Reusser P(2021)The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update J Hematol Oncol 14 145-748
[9]
Einsele H(2005)Efficacy of the interleukin-2 receptor antagonist basiliximab in steroid-refractory acute graft-versus-host disease Br J Haematol 130 568-458
[10]
Cordonnier C(2009)Therapy with mycophenolate mofetil for refractory acute and chronic GVHD Bone Marrow Transplant 44 739-440